Net Income

AM Best's 'a-' rating on Ameriprise's new notes isn't just a grade; it's a testament to strategic foresight and a beacon for investors.

Hyperscale Data is deploying humanoid robots in its Michigan data center, a high-stakes bet to teach AI about the real world amid major financial pressures.

American Outdoor Brands faces a key test on June 25. With mixed results and a shifting market, can its innovation strategy deliver on investor hopes?

Despite a dip in NAV, Northern Venture Trust raises £30M and maintains dividends, bracing for the impact of a major VCT tax relief cut on UK startups.

Northern 2 VCT holds dividends steady despite an NAV dip, celebrating a major IPO while facing new principal risks from AI and UK tax policy changes.

With its new 'Edge' plans, the nation's largest customer-owned insurer is using digital tools and psychological 'nudges' to guide patient choices.

AIFU, a Chinese fintech firm on the brink, plans to acquire a waste-tech AI company. Is this a visionary leap into green industry or a desperate gamble?

With a promising cancer therapy but precarious finances, Propanc Biopharma's stock buyback raises a critical question: is it a sign of confidence or a high-stakes gamble?

RenX just wiped $7M of debt in a savvy insider deal. It’s more than a balance sheet fix—it’s a calculated bet on a tech-driven, sustainable future.

A key deal locking in generic drug prices is extended, promising billions in savings for healthcare and providing crucial stability for a fragile industry.

A Nasdaq non-compliance notice threatens BIO-key's listing, revealing a pattern of reporting delays that casts a shadow over its operational wins.

Aethlon Medical is advancing a device to filter pathogens from the bloodstream, viewing it as a firewall for the body's internal communication network.

The marine tech firm posted another quarter of positive Adjusted EBITDA, but a sharp drop in orders reveals deep industry headwinds. Is its stable after-market business enough?

As Kewaunee Scientific preps its year-end report, all eyes are on whether its bold Nu Aire acquisition can translate revenue gains into long-term profit.

A new platform signals a major shift, turning the chaotic maze of ESG rules into a strategic playbook for product companies. Is this the future of compliance?

After a decade as a state bank, Jeff Bank is returning to a national charter. This move streamlines regulation and leverages federal law to gain a vital edge.

A major financial outlook warns that geopolitical fragmentation, stubborn inflation, and a new AI arms race are creating a new reality for investors.

Soaring healthcare costs, fueled by GLP-1 drugs, have employers trapped. A new report shows why flexible benefits are becoming a critical survival strategy.

China's POP Culture Group reports a 141% revenue surge, fueled by digital. But as live events wane, can its IP-focused strategy win in a market of giants?

The asset manager's May report reveals $3.3B in net inflows, driven by a major target date fund win, underscoring its market resilience and leadership.